Stock Markets June 25, 2026 08:32 AM

McCormick Shares Jump After Quarterly Beat and Reaffirmed Guidance

Strong Consumer unit performance and improved cash flow underpin pre-market rally despite tariff and M&A complexities

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
MKC

McCormick & Company shares advanced 3.2% in pre-open trading after the company reported second-quarter fiscal 2026 results that exceeded analyst expectations on both revenue and adjusted earnings, while maintaining its full-year earnings outlook. Robust sales in the Consumer segment, better operating income, and a swing to positive free cash flow were key drivers of investor optimism amid lingering concerns about tariffs and an ongoing merger review.

McCormick Shares Jump After Quarterly Beat and Reaffirmed Guidance
MKC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • McCormick beat analyst estimates on both adjusted EPS ($0.80 vs $0.70) and net sales ($1.94B vs $1.91B), with overall revenue up 16.7% year over year.
  • Consumer segment led growth with sales up 22.8% to $1.14B; Flavor Solutions rose 8.9% to $794M. Adjusted operating income rose 30.1% to $336M and free cash flow turned positive at $337.1M.
  • Management reaffirmed fiscal 2026 adjusted EPS guidance at a midpoint of $3.09, while investors weigh elevated tariff exposure and the pending Unilever Foods merger.

McCormick & Company saw its stock rise 3.2% in pre-market trading following the release of second-quarter fiscal 2026 results that outpaced Wall Street projections on both the top and bottom lines and included a reaffirmation of full-year guidance.

The company reported adjusted earnings per share of $0.80, above the $0.70 consensus among analysts. Net sales reached $1.94 billion, topping estimates of $1.91 billion and representing year-over-year growth of 16.7%.

Segment results were a notable part of the beat. The Consumer segment registered a 22.8% increase in sales to $1.14 billion. Management attributed part of that gain to the January 2026 consolidation of McCormick de Mexico and to increased demand for spices and seasonings as consumers have been cooking more at home amid inflationary pressures. The Flavor Solutions segment also contributed to the topline, with sales rising 8.9% to $794 million driven by organic gains across Flavors and Branded Foodservice customers.

Profitability measures improved as well. Adjusted operating income climbed 30.1% to $336 million. Free cash flow moved from a deep negative position in the prior period to $337.1 million in the quarter, a significant swing that underscored the operational improvement.

Management reiterated its fiscal 2026 adjusted EPS guidance, keeping the midpoint at $3.09. That confirmation provided investors with additional confidence even as the company faces elevated tariff exposure and the complexities associated with the pending Unilever Foods merger.

Options market activity had already signaled heightened investor interest heading into the report, with call volume jumping to its highest level since May 2025 on the eve of the earnings release. That surge in calls indicated expectations for a material move around the quarterly results.

The broader U.S. equity market provided a mixed backdrop. The S&P 500 was effectively flat on the session, while the Dow Jones Industrial Average posted a modest gain. Those broader market moves suggest the strength in McCormick shares was driven primarily by company-specific fundamentals rather than by a broad market tailwind.

McCormick shares had been under pressure over the prior year, falling well short of their 52-week high of $78.16. The better-than-expected quarter and reaffirmed guidance offered relief to investors who had been wary of the company’s tariff exposure and the size and implications of the proposed Unilever transaction.

Taken together, the combination of a clear earnings beat, resilient consumer demand for flavor products, a marked improvement in operating income and free cash flow, and sustained guidance helped spark the pre-market rally. Analysts continue to hold a consensus Buy rating on the stock, with a mean price target of $61.23.


Key takeaways

  • McCormick exceeded expectations on adjusted EPS and net sales, with adjusted EPS of $0.80 versus a $0.70 consensus and net sales of $1.94 billion versus $1.91 billion estimated.
  • Consumer sales grew 22.8% to $1.14 billion, aided by the consolidation of McCormick de Mexico and stronger at-home cooking demand; Flavor Solutions rose 8.9% to $794 million.
  • Adjusted operating income increased 30.1% to $336 million and free cash flow swung to $337.1 million, while management reaffirmed fiscal 2026 adjusted EPS guidance at a midpoint of $3.09.

Risks and uncertainties

  • Elevated tariff exposure could continue to pressure margins and cost structure, affecting the packaged food and consumer staples sectors.
  • The pending Unilever Foods merger remains complex and could introduce regulatory or operational uncertainty for McCormick and investors in food-related equities.
  • While consumer demand for spices and seasonings strengthened this quarter, shifts in consumer behavior or spending amid inflationary conditions could still influence future sales in the Consumer and Foodservice markets.

Risks

  • Elevated tariff exposure that could affect margins in the packaged food and consumer staples sectors.
  • Complexity and uncertainty associated with the pending Unilever Foods merger that could introduce regulatory or operational risks for McCormick.
  • Potential variability in consumer demand for spices and seasonings as economic conditions and inflation influence at-home food spending.

More from Stock Markets

Dell Shares Drop After Apple Memory Shortage Warning and Analyst Cut Jun 25, 2026 SanDisk Shares Jump After Analyst Upgrade and Strong Peer Results Lift NAND Outlook Jun 25, 2026 Corning Shares Leap to Record as Optical Infrastructure Optimism Spreads Jun 25, 2026 Acuity Brands Rallies After Fiscal Q3 Beat as Intelligent-Spaces Unit Drives Margin Expansion Jun 25, 2026 Kymera Shares Soar After Faster-Than-Expected Trial Enrollment Moves Key Data Up Six Months Jun 25, 2026